Measuring Persistency with Drug Therapy in Glaucoma ManagementVolume8 Issue 10 Suppl
An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension